BE896872A - Agent pour augmenter l'activite antitumorale d'un agent antitumorale. - Google Patents

Agent pour augmenter l'activite antitumorale d'un agent antitumorale.

Info

Publication number
BE896872A
BE896872A BE0/210868A BE210868A BE896872A BE 896872 A BE896872 A BE 896872A BE 0/210868 A BE0/210868 A BE 0/210868A BE 210868 A BE210868 A BE 210868A BE 896872 A BE896872 A BE 896872A
Authority
BE
Belgium
Prior art keywords
agent
antitumor
increasing
activity
antitumor activity
Prior art date
Application number
BE0/210868A
Other languages
English (en)
Original Assignee
Japan Found Cancer
Tabane Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Found Cancer, Tabane Seiyaku Co Ltd filed Critical Japan Found Cancer
Publication of BE896872A publication Critical patent/BE896872A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
BE0/210868A 1982-05-28 1983-05-27 Agent pour augmenter l'activite antitumorale d'un agent antitumorale. BE896872A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57091850A JPS58208222A (ja) 1982-05-28 1982-05-28 抗腫瘍剤効果増強剤

Publications (1)

Publication Number Publication Date
BE896872A true BE896872A (fr) 1983-09-16

Family

ID=14038043

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/210868A BE896872A (fr) 1982-05-28 1983-05-27 Agent pour augmenter l'activite antitumorale d'un agent antitumorale.

Country Status (11)

Country Link
US (1) US4628047A (fr)
JP (1) JPS58208222A (fr)
BE (1) BE896872A (fr)
CH (1) CH654212A5 (fr)
DE (1) DE3319347A1 (fr)
DK (1) DK239883A (fr)
FR (1) FR2527441B1 (fr)
GB (1) GB2120941B (fr)
IT (1) IT1208480B (fr)
NL (1) NL8301913A (fr)
SE (1) SE462076B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59231018A (ja) * 1983-06-10 1984-12-25 Tanabe Seiyaku Co Ltd 抗脂血剤
FR2593395A1 (fr) * 1986-01-28 1987-07-31 Corbiere Jerome Nouvelles compositions pharmaceutiques antiglaucomateuses a base de 3-acetoxy-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepine-4-one ou d'un de ses sels et leur procede d'obtention
FR2597750B1 (fr) * 1986-04-25 1989-06-02 Pf Medicament Solution aqueuse stable de sulfate de vincristine
DE3705117A1 (de) * 1987-02-18 1988-09-01 Goedecke Ag Verwendung von benzothiazepin-derivaten, insbesondere diltiazem bei der protektion von lymphozyten
US5112954A (en) * 1988-02-26 1992-05-12 Neorx Corporation Method of enhancing the effect of cytotoxic agents
US5114951A (en) * 1989-04-11 1992-05-19 Burroughs Wellcome Company Agents for combating multiple drug resistance
GB8914040D0 (en) * 1989-06-19 1989-08-09 Wellcome Found Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
GB8914061D0 (en) * 1989-06-19 1989-08-09 Wellcome Found Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
GB8914060D0 (en) * 1989-06-19 1989-08-09 Wellcome Found Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
GB8914062D0 (en) * 1989-06-19 1989-08-09 Wellcome Found Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
US5208238A (en) * 1989-06-19 1993-05-04 Burroughs Wellcome Company Agents for potentiating the effects of antitumor agents and combating multiple drug resistance
IE902182A1 (en) * 1989-06-19 1991-01-02 Wellcome Found Medicaments
CA2030160A1 (fr) * 1989-11-22 1991-05-23 Nahed K. Ahmed Traitement des metastases a l'aide de benzothiazepines
CA2030159A1 (fr) * 1989-11-22 1991-05-23 Nahed K. Ahmed Agents de potentialisation anticancereux
JPH0497451U (fr) * 1991-01-16 1992-08-24
GB2291279B (en) * 1994-06-24 1998-07-15 Thomas & Betts Corp Improvements in or relating to electrical connection apparatus
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof

Also Published As

Publication number Publication date
GB2120941A (en) 1983-12-14
DK239883D0 (da) 1983-05-27
DE3319347C2 (fr) 1992-03-19
SE8303003L (sv) 1983-11-29
IT1208480B (it) 1989-07-10
DK239883A (da) 1983-11-29
JPS6343366B2 (fr) 1988-08-30
FR2527441B1 (fr) 1986-05-09
US4628047A (en) 1986-12-09
GB8314588D0 (en) 1983-06-29
FR2527441A1 (fr) 1983-12-02
SE8303003D0 (sv) 1983-05-27
SE462076B (sv) 1990-05-07
NL8301913A (nl) 1983-12-16
DE3319347A1 (de) 1983-12-01
JPS58208222A (ja) 1983-12-03
GB2120941B (en) 1986-09-10
IT8321348A0 (it) 1983-05-27
CH654212A5 (de) 1986-02-14

Similar Documents

Publication Publication Date Title
BE896872A (fr) Agent pour augmenter l'activite antitumorale d'un agent antitumorale.
IT7922540A0 (it) Apparecchiatura per la combinazione di segnali.
IT8421855A0 (it) Apparecchio per l'applicazione di forza.
FR2552551B3 (fr) Montage-amplificateur pour un detecteur d'acceleration
ES262762Y (es) "estructura de casquillo".
RO75967A (fr) Cerceau d'oreille pour betes
FR2450014B1 (fr) Circuit d'asservissement pour magnetoscope
OA07768A (fr) Dérivés d'anillines fongicides.
FR2495410B1 (fr) Annuleur d'echo
IT1200442B (it) Dispositivo per l'elaborazione di segnali elettrooculografici
IT8021543A0 (it) Preparazione di idrossiderivati dell'isopropilammino-pirimidina (attraverso riduzione conidrogeno).
FR2534874B1 (fr) Navire de type " prao "
FR2497795B1 (fr) Catalyseur d'oxydeshydrogenation
BE870461A (fr) Groupe d'essieux combines pour remorques
ES514167A0 (es) "procedimiento de obtencion de benzhidrilpiperazinas".
BE887906A (fr) Systeme d'ordinateurs repondant
IT8119770A0 (it) Metodo per la riduzione della tossicita'.
ES511895A0 (es) "metodo mejorado de obtencion de derivados 5-bromoecilaminometilixoxaxolicos".
IT8120792A0 (it) Procedimento per l'ossidazione di idrocarburi.
IT8023748A0 (it) Macchina per l'assemblaggio diporte.
NL179357C (nl) Fender of stootkussen.
ES508567A0 (es) "procedimiento de obtencion de un derivado de ribosa con actividad antivirasica".
ES263581Y (es) "juego de palabras perfeccionado".
ES262233Y (es) "juego recreativo perfeccionado de bolsillo".
ES263787Y (es) "rebobinador de paginas".

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: TABANE SEIYAKU CO. LTD

Effective date: 19960531

Owner name: JAPANESE FOUNDATION FOR CANCER RESEARCH

Effective date: 19960531